Diffuse cutaneous dissemination of visceral leishmaniasis during human immunodeficiency virus (HIV) infection, despite negligible immunodeficiency: repeated failure of liposomal amphotericin B administration, followed by successful long-term pentamidine and paromomycin administration.
Manfredi
Roberto
R
Marinacci
Ginevra
G
Calza
Leonardo
L
Passarini
Beatrice
B
D000328:Adult; D000666:Amphotericin B / Q000008:administration & dosage / Q000627:therapeutic use*; D000981:Antiprotozoal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004337:Drug Carriers; D015658:HIV Infections / Q000150:complications* / Q000276:immunology / Q000821:virology; D006801:Humans; D007898:Leishmaniasis, Visceral / Q000150:complications* / Q000188:drug therapy*; D008081:Liposomes; D008297:Male; D010303:Paromomycin / Q000627:therapeutic use*; D010419:Pentamidine / Q000627:therapeutic use*; D017211:Treatment Failure
D000981:Antiprotozoal Agents; D004337:Drug Carriers; D008081:Liposomes; D010303:Paromomycin; D010419:Pentamidine; D000666:Amphotericin B